{"id":1939,"date":"2026-03-30T15:42:40","date_gmt":"2026-03-30T20:42:40","guid":{"rendered":"https:\/\/global-pharma.com.co\/?p=1939"},"modified":"2026-06-18T14:32:26","modified_gmt":"2026-06-18T19:32:26","slug":"semaglutida-generica-india-produccion-obesidad","status":"publish","type":"post","link":"https:\/\/global-pharma.com.co\/en\/semaglutida-generica-india-produccion-obesidad\/","title":{"rendered":"La producci\u00f3n de semaglutida gen\u00e9rica en India marca un giro hist\u00f3rico en el tratamiento global de la obesidad"},"content":{"rendered":"<p class=\"wp-block-paragraph\" id=\"ember574\">El panorama farmac\u00e9utico mundial acaba de dar un giro hist\u00f3rico. India, la &#8220;farmacia del mundo&#8221;, ha comenzado la producci\u00f3n de versiones gen\u00e9ricas de la <strong>semaglutida<\/strong> <strong>(el principio activo detr\u00e1s de Ozempic y Wegovy),<\/strong> tras la expiraci\u00f3n de sus patentes en mercados estrat\u00e9gicos.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"ember575\">Este movimiento no es solo una noticia corporativa; es el inicio de una transformaci\u00f3n en el tratamiento de la obesidad a escala global.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"ember576\">Los puntos clave de esta transici\u00f3n:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Desplome de precios:<\/strong> Se estima que el costo del tratamiento mensual podr\u00eda pasar de <strong>350 USD a tan solo 15 USD<\/strong> en mercados como el indio, e incluso alcanzar los <strong>3 USD<\/strong> en regiones con menores recursos.<\/li>\n\n\n\n<li><strong>Alcance masivo:<\/strong> Para finales de 2026, la protecci\u00f3n comercial habr\u00e1 expirado en pa\u00edses que representan casi el <strong>50% de la carga mundial de obesidad<\/strong>, incluyendo Brasil, China, Sud\u00e1frica y Canad\u00e1.<\/li>\n\n\n\n<li><strong>India toma la delantera:<\/strong> Gigantes como <em>Zydus Lifesciences<\/em> ya tienen listas sus versiones gen\u00e9ricas para inundar el mercado con m\u00e1s de 50 marcas alternativas.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"ember578\">El escenario para Occidente<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"ember579\">Aunque la democratizaci\u00f3n ha comenzado, <strong>Europa y Estados Unidos deber\u00e1n esperar hasta 2030<\/strong> debido a las protecciones regulatorias que buscan incentivar la innovaci\u00f3n. Esto plantea un reto log\u00edstico y \u00e9tico: la brecha de acceso a medicamentos de \u00faltima generaci\u00f3n entre mercados emergentes y econom\u00edas desarrolladas.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"ember580\">La respuesta de los gigantes<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"ember581\">Novo Nordisk y Eli Lilly no se quedan atr\u00e1s. Ante la p\u00e9rdida de exclusividad, la industria ya est\u00e1 pivotando hacia:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Versiones orales:<\/strong> Eliminando la barrera del pinchazo para retener la preferencia del paciente.<\/li>\n\n\n\n<li><strong>Reducci\u00f3n de costos preventivos:<\/strong> Ajustes de precio en mercados competitivos para frenar el avance de los gen\u00e9ricos.<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"ember583\">Una reflexi\u00f3n estrat\u00e9gica \ud83d\udca1<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"ember584\">La expiraci\u00f3n de una patente es el ciclo natural de la vida de un f\u00e1rmaco, pero en el caso de la semaglutida, estamos ante un fen\u00f3meno sin precedentes por su demanda global. Para quienes estamos en el sector , esto implica un nuevo desaf\u00edo en la cadena de suministro y una oportunidad para replantear el acceso a la salud.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"ember585\"><strong>\u00bfEstamos preparados para la presi\u00f3n log\u00edstica que supondr\u00e1 la distribuci\u00f3n masiva de estos gen\u00e9ricos a nivel global?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\" id=\"ember586\"><strong>Source:<\/strong><a href=\"https:\/\/www.abc.es\/sociedad\/ozempic-pierde-patente-convierte-farmaco-generico-millones-20260321041745-nt.html\"><strong>https:\/\/www.abc.es\/sociedad\/ozempic-pierde-patente-convierte-farmaco-generico-millones-20260321041745-nt.html<\/strong><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>Tras la expiraci\u00f3n de patentes clave, India da inicio a la producci\u00f3n masiva de semaglutida gen\u00e9rica. Este acontecimiento promete un desplome dr\u00e1stico de costos y redefine el acceso global a los tratamientos avanzados contra la obesidad, planteando nuevos retos log\u00edsticos y comerciales para el sector farmac\u00e9utico.<\/p>","protected":false},"author":3,"featured_media":2072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_joinchat":[],"footnotes":""},"categories":[6],"tags":[],"class_list":["post-1939","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Semaglutida gen\u00e9rica: India inicia producci\u00f3n masiva<\/title>\n<meta name=\"description\" content=\"India inicia la producci\u00f3n de versiones gen\u00e9ricas de semaglutida tras la expiraci\u00f3n de patentes, proyectando un desplome hist\u00f3rico en los precios mundiales.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/global-pharma.com.co\/en\/semaglutida-generica-india-produccion-obesidad\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Semaglutida gen\u00e9rica: India inicia producci\u00f3n masiva\" \/>\n<meta property=\"og:description\" content=\"India inicia la producci\u00f3n de versiones gen\u00e9ricas de semaglutida tras la expiraci\u00f3n de patentes, proyectando un desplome hist\u00f3rico en los precios mundiales.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/global-pharma.com.co\/en\/semaglutida-generica-india-produccion-obesidad\/\" \/>\n<meta property=\"og:site_name\" content=\"Global Pharma &amp; Logistic S.A.S.\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-30T20:42:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-18T19:32:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/03\/Presentacion-Comercial-Global-Pharma-Logistic-3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Mar\u00eda Camila Sanchez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mar\u00eda Camila Sanchez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/semaglutida-generica-india-produccion-obesidad\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/semaglutida-generica-india-produccion-obesidad\\\/\"},\"author\":{\"name\":\"Mar\u00eda Camila Sanchez\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#\\\/schema\\\/person\\\/912625696b849a3374bc496e1df87a7c\"},\"headline\":\"La producci\u00f3n de semaglutida gen\u00e9rica en India marca un giro hist\u00f3rico en el tratamiento global de la obesidad\",\"datePublished\":\"2026-03-30T20:42:40+00:00\",\"dateModified\":\"2026-06-18T19:32:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/semaglutida-generica-india-produccion-obesidad\\\/\"},\"wordCount\":402,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/semaglutida-generica-india-produccion-obesidad\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Presentacion-Comercial-Global-Pharma-Logistic-3.png\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/global-pharma.com.co\\\/semaglutida-generica-india-produccion-obesidad\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/semaglutida-generica-india-produccion-obesidad\\\/\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/semaglutida-generica-india-produccion-obesidad\\\/\",\"name\":\"Semaglutida gen\u00e9rica: India inicia producci\u00f3n masiva\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/semaglutida-generica-india-produccion-obesidad\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/semaglutida-generica-india-produccion-obesidad\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Presentacion-Comercial-Global-Pharma-Logistic-3.png\",\"datePublished\":\"2026-03-30T20:42:40+00:00\",\"dateModified\":\"2026-06-18T19:32:26+00:00\",\"description\":\"India inicia la producci\u00f3n de versiones gen\u00e9ricas de semaglutida tras la expiraci\u00f3n de patentes, proyectando un desplome hist\u00f3rico en los precios mundiales.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/semaglutida-generica-india-produccion-obesidad\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/global-pharma.com.co\\\/semaglutida-generica-india-produccion-obesidad\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/semaglutida-generica-india-produccion-obesidad\\\/#primaryimage\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Presentacion-Comercial-Global-Pharma-Logistic-3.png\",\"contentUrl\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Presentacion-Comercial-Global-Pharma-Logistic-3.png\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/semaglutida-generica-india-produccion-obesidad\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/global-pharma.com.co\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La producci\u00f3n de semaglutida gen\u00e9rica en India marca un giro hist\u00f3rico en el tratamiento global de la obesidad\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#website\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/\",\"name\":\"Distribuidor de materias primas farmac\u00e9uticas en Colombia.\",\"description\":\"Principios Activos y Materias Primas en Colombia\",\"publisher\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/global-pharma.com.co\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#organization\",\"name\":\"Global Pharma & Logistic S.A.S.\",\"alternateName\":\"Global Pharma & Logistic S.A.S.\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/LOGO-COMPLETO2-02.jpg\",\"contentUrl\":\"https:\\\/\\\/global-pharma.com.co\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/LOGO-COMPLETO2-02.jpg\",\"width\":2133,\"height\":2133,\"caption\":\"Global Pharma & Logistic S.A.S.\"},\"image\":{\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/51710617\\\/admin\\\/dashboard\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/global-pharma.com.co\\\/#\\\/schema\\\/person\\\/912625696b849a3374bc496e1df87a7c\",\"name\":\"Mar\u00eda Camila Sanchez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g\",\"caption\":\"Mar\u00eda Camila Sanchez\"},\"url\":\"https:\\\/\\\/global-pharma.com.co\\\/en\\\/author\\\/maria-sanchez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Semaglutida gen\u00e9rica: India inicia producci\u00f3n masiva","description":"India inicia la producci\u00f3n de versiones gen\u00e9ricas de semaglutida tras la expiraci\u00f3n de patentes, proyectando un desplome hist\u00f3rico en los precios mundiales.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/global-pharma.com.co\/en\/semaglutida-generica-india-produccion-obesidad\/","og_locale":"en_US","og_type":"article","og_title":"Semaglutida gen\u00e9rica: India inicia producci\u00f3n masiva","og_description":"India inicia la producci\u00f3n de versiones gen\u00e9ricas de semaglutida tras la expiraci\u00f3n de patentes, proyectando un desplome hist\u00f3rico en los precios mundiales.","og_url":"https:\/\/global-pharma.com.co\/en\/semaglutida-generica-india-produccion-obesidad\/","og_site_name":"Global Pharma &amp; Logistic S.A.S.","article_published_time":"2026-03-30T20:42:40+00:00","article_modified_time":"2026-06-18T19:32:26+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/03\/Presentacion-Comercial-Global-Pharma-Logistic-3.png","type":"image\/png"}],"author":"Mar\u00eda Camila Sanchez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mar\u00eda Camila Sanchez","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/global-pharma.com.co\/semaglutida-generica-india-produccion-obesidad\/#article","isPartOf":{"@id":"https:\/\/global-pharma.com.co\/semaglutida-generica-india-produccion-obesidad\/"},"author":{"name":"Mar\u00eda Camila Sanchez","@id":"https:\/\/global-pharma.com.co\/#\/schema\/person\/912625696b849a3374bc496e1df87a7c"},"headline":"La producci\u00f3n de semaglutida gen\u00e9rica en India marca un giro hist\u00f3rico en el tratamiento global de la obesidad","datePublished":"2026-03-30T20:42:40+00:00","dateModified":"2026-06-18T19:32:26+00:00","mainEntityOfPage":{"@id":"https:\/\/global-pharma.com.co\/semaglutida-generica-india-produccion-obesidad\/"},"wordCount":402,"commentCount":0,"publisher":{"@id":"https:\/\/global-pharma.com.co\/#organization"},"image":{"@id":"https:\/\/global-pharma.com.co\/semaglutida-generica-india-produccion-obesidad\/#primaryimage"},"thumbnailUrl":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/03\/Presentacion-Comercial-Global-Pharma-Logistic-3.png","articleSection":["Blog"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/global-pharma.com.co\/semaglutida-generica-india-produccion-obesidad\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/global-pharma.com.co\/semaglutida-generica-india-produccion-obesidad\/","url":"https:\/\/global-pharma.com.co\/semaglutida-generica-india-produccion-obesidad\/","name":"Semaglutida gen\u00e9rica: India inicia producci\u00f3n masiva","isPartOf":{"@id":"https:\/\/global-pharma.com.co\/#website"},"primaryImageOfPage":{"@id":"https:\/\/global-pharma.com.co\/semaglutida-generica-india-produccion-obesidad\/#primaryimage"},"image":{"@id":"https:\/\/global-pharma.com.co\/semaglutida-generica-india-produccion-obesidad\/#primaryimage"},"thumbnailUrl":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/03\/Presentacion-Comercial-Global-Pharma-Logistic-3.png","datePublished":"2026-03-30T20:42:40+00:00","dateModified":"2026-06-18T19:32:26+00:00","description":"India inicia la producci\u00f3n de versiones gen\u00e9ricas de semaglutida tras la expiraci\u00f3n de patentes, proyectando un desplome hist\u00f3rico en los precios mundiales.","breadcrumb":{"@id":"https:\/\/global-pharma.com.co\/semaglutida-generica-india-produccion-obesidad\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/global-pharma.com.co\/semaglutida-generica-india-produccion-obesidad\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/global-pharma.com.co\/semaglutida-generica-india-produccion-obesidad\/#primaryimage","url":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/03\/Presentacion-Comercial-Global-Pharma-Logistic-3.png","contentUrl":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2026\/03\/Presentacion-Comercial-Global-Pharma-Logistic-3.png","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/global-pharma.com.co\/semaglutida-generica-india-produccion-obesidad\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/global-pharma.com.co\/"},{"@type":"ListItem","position":2,"name":"La producci\u00f3n de semaglutida gen\u00e9rica en India marca un giro hist\u00f3rico en el tratamiento global de la obesidad"}]},{"@type":"WebSite","@id":"https:\/\/global-pharma.com.co\/#website","url":"https:\/\/global-pharma.com.co\/","name":"Distribuidor de materias primas farmac\u00e9uticas en Colombia.","description":"Principios Activos y Materias Primas en Colombia","publisher":{"@id":"https:\/\/global-pharma.com.co\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/global-pharma.com.co\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/global-pharma.com.co\/#organization","name":"Global Pharma & Logistic S.A.S.","alternateName":"Global Pharma & Logistic S.A.S.","url":"https:\/\/global-pharma.com.co\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/global-pharma.com.co\/#\/schema\/logo\/image\/","url":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2025\/08\/LOGO-COMPLETO2-02.jpg","contentUrl":"https:\/\/global-pharma.com.co\/wp-content\/uploads\/2025\/08\/LOGO-COMPLETO2-02.jpg","width":2133,"height":2133,"caption":"Global Pharma & Logistic S.A.S."},"image":{"@id":"https:\/\/global-pharma.com.co\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/51710617\/admin\/dashboard\/"]},{"@type":"Person","@id":"https:\/\/global-pharma.com.co\/#\/schema\/person\/912625696b849a3374bc496e1df87a7c","name":"Mar\u00eda Camila Sanchez","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0329561f75938cb23698a3fea3fb2b239761b6609e52728bd3aef6667c8eecb3?s=96&d=mm&r=g","caption":"Mar\u00eda Camila Sanchez"},"url":"https:\/\/global-pharma.com.co\/en\/author\/maria-sanchez\/"}]}},"_links":{"self":[{"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/posts\/1939","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/comments?post=1939"}],"version-history":[{"count":4,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/posts\/1939\/revisions"}],"predecessor-version":[{"id":2155,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/posts\/1939\/revisions\/2155"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/media\/2072"}],"wp:attachment":[{"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/media?parent=1939"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/categories?post=1939"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/global-pharma.com.co\/en\/wp-json\/wp\/v2\/tags?post=1939"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}